Home / News

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO). Date on which the share buy-back programme was announced: 30 November 2022. The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General [...]

29/03/2023 |

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO). Date on which the share buy-back programme was announced: 30 November 2022. The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General [...]

20/03/2023 |

Transactions carried out under the share buy-back programme

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO). Date on which the share buy-back programme was announced: 30 November 2022. The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General [...]

09/03/2023 |

Lab technician using XY microscope

CSAM Customer Case: Nordic IVF

Nordic IVF has been providing assisted reproductive treatments since 2007. It is now part of the Eugin Group and encompasses four clinics - two in Stockholm and one in both Malmo and Gothenburg. All Nordic IVF’s clinics use CSAM Fertsoft software to manage data, inform clinical decision-making and ensure safe and effective treatments. “We use [...]

09/03/2023 |

Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO). Date on which the share buy-back programme was announced: 30 November 2022. The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General [...]

28/02/2023 |

CSAM delivers 12% growth in 2022, posting record full-year revenue of NOK 370 million

Oslo, Norway, 28 February 2023: Today, CSAM Health Group AS (CSAM), a leading provider of specialised software for healthcare, published its results for the fourth quarter of 2022. CSAM reports revenue of NOK 98 million for Q4-22, and full-year revenue totalling NOK 370 million, an increase of 12% over 2021. CSAM’s business model, with long-term [...]

28/02/2023 |

Invitation to presentation of CSAM Health Group’s Q4 results

CSAM Health Group AS (CSAM) will publish its results for the fourth quarter of 2022 on Tuesday, 28 February at 08:00 CET (UTC +1) on newsweb.oslobors.no and www.csamhealth.com/investor-relations. A presentation of the results, including a discussion of recent events, will be given by CEO Sverre Flatby and CFO Einar Bonnevie at 08:30 CET (UTC +1) [...]

22/02/2023 |

Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back programme for CSAM Health Group AS (“CSAM” or the “Company”) (Ticker: CSAM NO). Date on which the share buy-back programme was announced: 30 November 2022. The duration of the buy-back programme: 20 January 2023 until and including the day before the Company’s Annual General [...]

17/02/2023 |

Maternity Electronic Health Records and Virtual Maternity Care

As digitalisation in maternity care gathers pace, interest in maternity electronic health records (EHR) and the ways they enhance care provision is accelerating. Digital maternity records improve quality of care, facilitate better cross-discipline collaboration, include pregnant women in their care, and demystify pregnancy care provision. In this article, we explore the opportunities and discuss how [...]

13/02/2023 |

START TYPING AND PRESS ENTER TO SEARCH